SCHEMBL314598

SCHEMBL314598

C[C@@H]1CNc2ccc(Cl)cc2-n2c(-c3cccnc3)nnc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
HTT P42858 2/20 0.41
CYP11B2 P19099 2/20 0.40
CYP11B1 P15538 1/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
CNR1 P21554 1/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
NPBWR1 P48145 1/20 0.37
MCHR1 Q99705 1/20 0.37
BCHE P06276 2/20 0.37
CHRM1 P11229 1/20 0.37
OPRL1 P41146 1/20 0.36
KCNH2 Q12809 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
NR1I2 O75469 1/20 0.36
HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL314597 1.00 ALDH1A1 (0.46) ALDH1A1HTTCYP11B2CYP11B1MEN1
SCHEMBL314599 1.00 ALDH1A1 (0.46) ALDH1A1HTTCYP11B2CYP11B1MEN1
SCHEMBL313656 0.89 HSD11B1 (0.41) ALDH1A1HTTCNR1LMNACHRM1
SCHEMBL313657 0.89 HSD11B1 (0.41) ALDH1A1HTTCNR1LMNACHRM1
SCHEMBL313658 0.89 HSD11B1 (0.41) ALDH1A1HTTCNR1LMNACHRM1
SCHEMBL316031 0.88 MAPK10 (0.35) HTTBCHEHSD11B1
SCHEMBL316029 0.88 MAPK10 (0.35) HTTBCHEHSD11B1
SCHEMBL316030 0.88 MAPK10 (0.35) HTTBCHEHSD11B1
SCHEMBL314787 0.82 ALDH1A1 (0.45) ALDH1A1HTTMEN1KMT2ACNR1
SCHEMBL315856 0.82 ALDH1A1 (0.45) ALDH1A1HTTMEN1KMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP claimed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US claimed
US-8093240-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2012-01-10 US disclosed
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP disclosed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306042-A1 Triazole Derivatives TGFBR1, TGFBR2, SMAD3 ALDH1A1 2295/4885HTT 4673/4885CYP11B2 2270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.